rs72552294
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PP3_ModerateBS2
The NM_015141.4(GPD1L):c.817C>T(p.Arg273Cys) variant causes a missense change. The variant allele was found at a frequency of 0.000057 in 1,613,638 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R273H) has been classified as Uncertain significance.
Frequency
Consequence
NM_015141.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
GPD1L | NM_015141.4 | c.817C>T | p.Arg273Cys | missense_variant | 6/8 | ENST00000282541.10 | |
GPD1L | XM_006713068.3 | c.676C>T | p.Arg226Cys | missense_variant | 5/7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
GPD1L | ENST00000282541.10 | c.817C>T | p.Arg273Cys | missense_variant | 6/8 | 1 | NM_015141.4 | P1 | |
GPD1L | ENST00000474846.5 | n.741C>T | non_coding_transcript_exon_variant | 1/3 | 2 | ||||
GPD1L | ENST00000496151.1 | n.318C>T | non_coding_transcript_exon_variant | 1/3 | 2 | ||||
GPD1L | ENST00000428684.1 | c.*444C>T | 3_prime_UTR_variant, NMD_transcript_variant | 5/6 | 5 |
Frequencies
GnomAD3 genomes ? AF: 0.0000329 AC: 5AN: 152192Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000482 AC: 12AN: 249208Hom.: 0 AF XY: 0.0000518 AC XY: 7AN XY: 135140
GnomAD4 exome AF: 0.0000595 AC: 87AN: 1461446Hom.: 0 Cov.: 34 AF XY: 0.0000523 AC XY: 38AN XY: 727016
GnomAD4 genome ? AF: 0.0000329 AC: 5AN: 152192Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74354
ClinVar
Submissions by phenotype
not provided Uncertain:3
Uncertain significance, no assertion criteria provided | clinical testing | Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+ | - | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Sep 04, 2015 | The R273C variant of unknown significance in the GPD1L gene has been reported previously in one case of sudden infant death syndrome (SIDS) and was absent in 600 control alleles (Van Norstrand et al., 2007). However, additional clinical and family history information on this case was not available due to the blinded nature of this study. Functional studies showed that GPD1L containing the R273C variant caused a significant reduction in sodium channel current when co-expressed with SCN5A in cultured cells (Van Norstrand et al., 2007), however, this assay does not reflect the heterozygous state in a human cardiomyocyte and may not accurately reflect the impact of this variant in vivo. The R273C mutation was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. The R273C mutation is a non-conservative change at a conserved residue. In silico analysis is inconsistent in its predictions as to whether or not the variant is damaging to the protein structure/function.Therefore, based on the currently available information, it is unclear whether this variant is a pathogenic mutation or a rare benign variant - |
Uncertain significance, no assertion criteria provided | clinical testing | Clinical Genetics, Academic Medical Center | - | - - |
Brugada syndrome 2 Pathogenic:1Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Oct 16, 2021 | - - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Nov 13, 2007 | - - |
Brugada syndrome Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Invitae | Sep 15, 2023 | This sequence change replaces arginine, which is basic and polar, with cysteine, which is neutral and slightly polar, at codon 273 of the GPD1L protein (p.Arg273Cys). This variant is present in population databases (rs72552294, gnomAD 0.01%). This missense change has been observed in individual(s) with clinical features of GPD1L-related conditions (PMID: 17967976, 30847666). ClinVar contains an entry for this variant (Variation ID: 789). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on GPD1L protein function. Experimental studies have shown that this missense change affects GPD1L function (PMID: 17967976). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Cardiovascular phenotype Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 11, 2022 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at